Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
160,529,963
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
34,818,530
-
Shares change
-
+800,106
-
Total reported value, excl. options
-
$317,890,500
-
Value change
-
+$6,996,481
-
Put/Call ratio
-
1.05%
-
Number of buys
-
58
-
Number of sells
-
-46
-
Price
-
$9.13
Significant Holders of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) as of Q2 2021
121 filings reported holding GRTS - Gritstone bio, Inc. - Common Stock, $0.0001 par value per share as of Q2 2021.
Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34,818,530 shares
of 160,529,963 outstanding shares and own 21.69% of the company stock.
Largest 10 shareholders include Versant Venture Management, LLC (4,450,638 shares), EcoR1 Capital, LLC (3,421,287 shares), BlackRock Inc. (2,854,868 shares), FMR LLC (2,795,412 shares), Palo Alto Investors LP (2,356,282 shares), Redmile Group, LLC (2,226,206 shares), Avidity Partners Management LP (2,122,064 shares), BVF INC/IL (1,826,494 shares), VANGUARD GROUP INC (1,423,249 shares), and D. E. Shaw & Co., Inc. (1,254,720 shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.